申联生物(688098.SH)上半年净亏损1286.97万元

Summary of Key Points Core Viewpoint - Shenlian Bio (688098.SH) reported a decline in revenue for the first half of 2025, indicating challenges in its financial performance [1] Financial Performance - The company achieved total operating revenue of 122 million yuan in the first half of 2025, representing a year-on-year decrease of 3.68% [1] - The net profit attributable to shareholders of the parent company was -12.87 million yuan, which is an improvement of 21.64 million yuan compared to the same period last year [1] - The basic earnings per share stood at -0.03 yuan [1]